Abstract:Abstract 5α-reductase type 2 (5αR2) deficiency is an autosomal recessive inherited condition affecting 46,XY individuals resulting from the inability to convert testosterone into dihydrotestosterone. Affected individuals present a range of external genitalia undervirilization at birth and pronounced masculinization at puberty. Unlike most other 46,XY DSD, the frequency of gender change among 5αR2 deficiency is high. Objective to analyze the 451 individuals carrying pathogenic 5αR2 variants in the SRD5A2 gene in both alleles (in homozygous or compound heterozygous state) in the literature (Pubmed, EMBASE, Medline) and websites (ensemble, HGMD, ClinVar) regarding sex assignment, external genitalia virilization (1-5 Sinnecker score), and gender change accordingly country income Methods A total of 357 cases out of 451 had clinical information. All patients included were divided between those born before or after 2006 (the DSD consensus year). Country income was based on the 2018 World Bank classification, classifying income into four categories: low, lower-middle, upper-middle, and high (www.worldbank.org). Categorical variables were analyzed using the Chi-square test followed by the Cramer's V. Continuous variables were analyzed either by Student t-test or ANOVA one way. A binary logistic regression was built using sex assignment and gender change as categorical dependent variables. A p<.05 was considered significant. Results When we divided the individuals into those diagnosed after and before 2006, the percentage of female sex assignments dropped from 72% to 56% (p<.0001), followed by an odds ratio reduction (from 2.52 to 1.65) for female sex assignment. Country income did not impact sex assignment (p=.21). However, most cases (86%) were reported from countries with high and upper-middle economies. The absence of reports from low-income countries may be due to several reasons, such as barriers to molecular diagnosis, scientific access, and specialized medical assistance. Most cases were assigned as female (69%). The overall rate of gender change was 25% (89 out 357). All but one changed their gender from female to male. The rate of gender change was significantly different across all countries (V=0.46; p<.001), but it ranged from 16% to 70%, and gender change was lower among those diagnosed after 2006 (p=.01). The association between less external genitalia virilization and female sex assignment was significant (p<.001). On the other hand, the virilization score was similar between those who kept or changed gender (p=.37). Neither the type of SRD5A2 variant (missense, nonsense, indel) nor zygosity (homo/hetero) impacted sex assignment or gender change. Conclusion An apparent temporal trend indicates an increased likelihood of affected 5αR2 deficiency individuals being raised as boys, providing a gender change drop. The external virilization degree influenced sex assignment, but it does not affect gender change. There is no correlation between either both sex assignment and gender development with 5αR2 genetics. Presentation: Saturday, June 11, 2022 1:06 p.m. - 1:11 p.m., Saturday, June 11, 2022 1:06 p.m. - 1:11 p.m., Monday, June 13, 2022 12:30 p.m. - 2:30 p.m.

Testicular histological and immunohistochemical aspects in a post-pubertal patient with 5 alpha-reductase type 2 deficiency: case report and review of the literature in a perspective of evaluation of potential fertility of these patients

Clinical and molecular characterization of 5α-reductase type 2 deficiency due to mutations (p.Q6X, p.R246Q) in SRD5A2 gene.

RF02 | PMON189 Temporal and Social trends towards sex assignment and gender change in the 5α-reductase type 2 deficiency

Ontogeny of the androgen receptor expression in the fetal and postnatal testis: Its relevance on Sertoli cell maturation and the onset of adult spermatogenesis

Clinical, Hormonal, and Genetic Characteristics of 5a-Reductase Type 2 Deficiency in 103 Chinese Patients

The Analysis of Gene Mutation and Diagnosis and Treatment of 5Α-Reductase 2 Deficiency in a Child

Phenotypic and Molecular Characteristics in Eleven Chinese Patients with 5α‐reductase Type 2 Deficiency

The Correlation Between Phenotype and Genotype of 5Α-Reductase 2 Deficiency in 5 Children

Importance of Serum Testicular Protein Hormone Measurement in the Assessment of Disorders of Sex Development

Testicular Function of Childhood Cancer Survivors: Who Is Worse?

Identification of Three Novel SRD5A2 Mutations in Chinese Patients with 5Α-Reductase 2 Deficiency.

Four novel mutations identification in 17 beta-hydroxysteroid dehydrogenase-3 deficiency and our clinical experience: possible benefits of early treatment

Partial rejuvenation of the spermatogonial stem cell niche after gender-affirming hormone therapy in trans women

New Insights into 5Α-Reductase Type 2 Deficiency Based on a Multi-Centre Study: Regional Distribution and Genotype–phenotype Profiling Ofsrd5a2in 190 Chinese Patients

A Case Report on 46,XX Male Difference of Sex Development

AMH Regulation by Steroids in the Mammalian Testis: Underlying Mechanisms and Clinical Implications

Ultrastructural And Histopathological Investigation Of Seminiferous Tubules Obtained From Azoospermia Cases In The IVF Center

5α Reductase Deficiency-a Rare Cause of Ambiguous Genitalia and Gender Dysphoria

Expression and characterization of androgen receptor coregulators, SRC-2 and HBO1, during human testis ontogenesis and in androgen signaling deficient patients

SUN-362 Differences in Both Gonadal and Adrenal-Derived Androgens in 5α-Reductase Deficiency versus Androgen Insensitivity Syndrome and Normal Chinese Men Using LC-MS/MS

Up-Regulation of SOX9 in Sertoli Cells from Testiculopathic Patients Accounts for Increasing Anti-Mullerian Hormone Expression via Impaired Androgen Receptor Signaling